Skip to main content

dorsaVi (ASX: DVL) — Company Overview, News & Financial Data

dorsaVi logo
DVL dorsaVi
dorsaVi primary media
Company profile

dorsaVi

dorsaVi is a medical technology company that develops and markets wearable sensor systems, artificial intelligence software, and motion analysis solutions. Founded in 2008, the company creates wearable wireless inertial measurement sensors and video movement assessment tools for clinical, athletic, and workplace safety applications. Its technology measures human movement, posture, and ergonomic risk factors, delivering objective biomechanical data in real time. dorsaVi serves physical therapy clinics, professional sports teams, enterprise occupational safety programs, and research institutions across Australia, the United States, and international markets.

Snapshot

Public AUOwnership
2008Year founded
11–50Employees
Oakleigh South, AustraliaHead office
Loading Map...
Global footprint

Operations

Products and/or services of dorsaVi

  • Clinical Motion Analysis: Wearable wireless inertial measurement unit sensors and software that capture objective biomechanical data, aiding physical therapists and athletic trainers in assessing lower back and joint movement, tracking rehabilitation, and guiding injury recovery programs.
  • Artificial Intelligence Video Assessment: Sensorless video motion analysis software utilizing computer vision algorithms to evaluate running gait and limb movement angles in real time, serving physical therapy clinics, fitness facilities, and sports performance centers.
  • Workplace Safety Solutions: Industrial wearable sensors and data analytics software for monitoring employee movement and manual handling activities, identifying ergonomic hazard patterns, and evaluating risk reduction interventions across manufacturing, logistics, and corporate environments.
  • Biomechanical Research Tools: Precision movement capture software and sensor hardware supporting high-frequency sampling, electromyography integration, and custom algorithms, enabling academic and clinical research teams to analyze dynamic body movement and kinematic metrics.
  • Semiconductor Innovation: Development of advanced resistive random-access memory technology to power next-generation intelligent physical systems, enabling ultra-low-power microcontrollers and edge processing capabilities for compact wearable sensor applications and medical devices.
  • Ergonomic Monitoring Software: Specialized software applications and body-worn sensors providing real-time posture feedback, automated safety risk scoring, and continuous health status tracking for enterprise employees and healthcare clinical management systems.

dorsaVi executive team

  • Gernot Kurt AblExecutive Chairman
  • Mathew ReganGroup Chief Executive Officer
  • Andrew James RonchiCo-Founder & CEO of Sensor Division
  • Aaron ChanChief Financial Officer
  • Mary StewartAccount Manager & Head of Clinical Sales
  • Daniel Mathew RonchiChief Technology Officer
  • Justin MouchaccaCompany Secretary

Recent announcements

What dorsaVi (DVL) has told the market, newest first.

  1. Notification of cessation of securities - DVL
  2. 2026 AGM - Letter to Shareholders & Proxy Form
  3. Notice of Annual General Meeting/Proxy Form
  4. Section 708A Cleansing Notice
  5. Notification regarding unquoted securities - DVL
  6. Notification regarding unquoted securities - DVL
  7. Application for quotation of securities - DVL
  8. Notification regarding unquoted securities - DVL

Key financials

Reported results for dorsaVi, in AUD.

Market cap
26M
Revenue (TTM)
1M
P/E ratio
—
EPS (diluted, TTM)
-0.0
Dividend yield
—
Profit margin
0.0%
dorsaVi annual revenue and income
Fiscal year endRevenueOperating incomeNet income
1M-7.5M-8.5M
1.1M-1.9M-1.5M
1.3M-1.7M-1.2M
1.8M-2.4M-1.8M